Literature DB >> 21112206

Survival of the fittest: metabolic adaptations in cancer.

Marcelo J Berardi1, Valeria R Fantin.   

Abstract

Malignant transformation is often a multistep process characterized by an initial period of avascular growth. Rapid cell proliferation creates areas within the emerging preneoplastic lesion with limited diffusion of oxygen and nutrients. In this context, activation of oncogenes, loss of tumor suppressors as well as additional adaptive mechanisms drive a profound metabolic rewiring to overcome the environmental constraints. The emerging cells are in principle better suited to proliferate and survive in the hostile tumor microenvironment. Furthermore, some of the acquired metabolic traits impact their metastatic behavior and response to therapy. It is becoming increasingly clear that malignant cells are highly dependent on certain nutrients, an Achilles' heel of cancer and an opportunity for therapeutic intervention.
Copyright © 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21112206     DOI: 10.1016/j.gde.2010.10.001

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  9 in total

Review 1.  Metabolic Dependencies in RAS-Driven Cancers.

Authors:  Alec C Kimmelman
Journal:  Clin Cancer Res       Date:  2015-04-15       Impact factor: 12.531

2.  Effect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cells.

Authors:  Anna V Kudryavtseva; Maria S Fedorova; Alex Zhavoronkov; Alexey A Moskalev; Alexander S Zasedatelev; Alexey A Dmitriev; Asiya F Sadritdinova; Irina Y Karpova; Kirill M Nyushko; Dmitry V Kalinin; Nadezhda N Volchenko; Nataliya V Melnikova; Kseniya M Klimina; Dmitry V Sidorov; Anatoly Y Popov; Tatiana V Nasedkina; Andrey D Kaprin; Boris Y Alekseev; George S Krasnov; Anastasiya V Snezhkina
Journal:  BMC Genet       Date:  2016-12-22       Impact factor: 2.797

3.  Good neighbours in the tumour stroma reduce oxidative stress.

Authors:  Ralph J DeBerardinis
Journal:  Nat Cell Biol       Date:  2012-02-19       Impact factor: 28.824

Review 4.  Homeostasis and the importance for a balance between AKT/mTOR activity and intracellular signaling.

Authors:  D A Altomare; A R Khaled
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

5.  Proteomic analysis of proton beam irradiated human melanoma cells.

Authors:  Sylwia Kedracka-Krok; Urszula Jankowska; Martyna Elas; Urszula Sowa; Jan Swakon; Agnieszka Cierniak; Pawel Olko; Bozena Romanowska-Dixon; Krystyna Urbanska
Journal:  PLoS One       Date:  2014-01-02       Impact factor: 3.240

Review 6.  Metabolic alterations in cancer cells and therapeutic implications.

Authors:  Naima Hammoudi; Kausar Begam Riaz Ahmed; Celia Garcia-Prieto; Peng Huang
Journal:  Chin J Cancer       Date:  2011-08

7.  Development of safer gene delivery systems to minimize the risk of insertional mutagenesis-related malignancies: a critical issue for the field of gene therapy.

Authors:  Gaetano Romano
Journal:  ISRN Oncol       Date:  2012-11-22

Review 8.  Systems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and "swarm intelligence".

Authors:  M Tarabichi; A Antoniou; M Saiselet; J M Pita; G Andry; J E Dumont; V Detours; C Maenhaut
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

9.  Glucocorticoid receptor knockdown decreases the antioxidant protection of B16 melanoma cells: an endocrine system-related mechanism that compromises metastatic cell resistance to vascular endothelium-induced tumor cytotoxicity.

Authors:  Elena Obrador; Soraya L Valles; María Benlloch; J Antoni Sirerol; José A Pellicer; Javier Alcácer; Javier Alcácer-F Coronado; José M Estrela
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.